Trials / Conditions / Adjuvant Drug Therapy
Adjuvant Drug Therapy
5 registered clinical trials studyying Adjuvant Drug Therapy — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening NCT07273357 | Region Jönköping County | — |
| Not Yet Recruiting | The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER NCT07502820 | Karolinska Institutet | Phase 3 |
| Recruiting | Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Th NCT07181499 | Betta Pharmaceuticals Co., Ltd. | Phase 2 |
| Enrolling By Invitation | Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation NCT06405295 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Terminated | Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and I NCT02718391 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 2 |